Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Apotex First In US To Recall OTC Ranitidine Tablets Due To NDMA Impurity
Sep 26 2019
•
By
Malcolm Spicer
Explore how consumer health is evolving. On the go.
David Ridley hosts in-depth conversations with industry leaders.
More from Recalls
More from Policy & Regulation